Evidence map›Paper›PMID 19349057›Full record

ArticleVirology2009

Rat cytomegalovirus infection depletes MHC II in bone marrow derived dendritic cells.

Carmen C Baca Jones, Craig N Kreklywich, Ilhem Messaoudi, Jennifer Vomaske, Erin McCartney, Susan L Orloff, Jay A Nelson, Daniel N Streblow

Open access · greenAbstract read
In one paragraph

Article in Virology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Frontiers in cellular neuroscience · 2018
    Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Carmen C Baca JonesDepartment of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR 97239, USA.
Craig N Kreklywich
Ilhem Messaoudi
Jennifer Vomaske
Erin McCartney
Susan L Orloff
Jay A Nelson
Daniel N Streblow
Oregon Health & Science University · US

Funding

MOLECULAR ASPECTS OF CYTOMEGALOVIRUS LATENCYR01AI021640 · NIAID · UNIVERSITY OF GUELPH · PI Meaghan H Hancock · 1985 to 2026
$8.1M
INTERACTIONS AT THE MICROBE/HOST INTERFACET32AI007472 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI LANDFEAR, SCOTT M · 1995 to 2019
$6.7M
Molecular Aspects of Cytomegalovirus LatencyR37AI021640 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI HANCOCK, MEAGHAN H · 2018 to 2024
$4.0M
CHEMOKINE RECEPTORS IN VASCULAR DISEASER01HL065754 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI NELSON, JAY A · 2000 to 2007
$2.7M
Cytomegalovirus Chemokine Receptors in Transplant Vascular SclerosisR01HL085451 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI ORLOFF, SUSAN L · 2009 to 2013
$2.2M
Cellular Basis of CMV Accelerated VasculopathyR01HL071695 · NHLBI · OREGON HEALTH AND SCIENCE UNIVERSITY · PI NELSON, JAY A · 2002 to 2005
$1.5M
Mechanisms of CMV latency in accelerated vascular diseaseR01HL083194 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI STREBLOW, DANIEL N · 2006 to 2010
$1.5M
VIRAL CHEMOKINE RECEPTORS: TRANSPLANT VASCULAR SCLEROSISR01HL066238 · NHLBI · OREGON HEALTH AND SCIENCE UNIVERSITY · PI ORLOFF, SUSAN L · 2001 to 2003
$793k
NHLBI NIH HHS HL083194NHLBI NIH HHS HL65754NHLBI NIH HHS HL 66238-01NHLBI NIH HHS HL71695NHLBI NIH HHS R01 HL065754NHLBI NIH HHS R01 HL066238NHLBI NIH HHS R01 HL071695NHLBI NIH HHS R01 HL083194NHLBI NIH HHS R01 HL085451NIAID NIH HHS AI07472NIAID NIH HHS AI21640NIAID NIH HHS R01 AI021640NIAID NIH HHS R37 AI021640NIAID NIH HHS T32 AI007472
6 · The paper itself

Abstract

While cytomegalovirus (CMV) infects and replicates in a multitude of cell types, the ability of the virus to replicate in antigen presenting cells (APCs) is believed to play a critical role in the viral dissemination and latency. CMV infection of APCs and manipulation of their function are important areas of investigation. CMV down regulation of MHC II is reportedly mediated by the HCMV proteins US2, US3, UL83, UL111a (vIL10) or through the induction of cellular IL10. In this study, we demonstrate that rat CMV (RCMV) significantly reduces MHC II expression neither by mechanisms that do not involve orthologues of the known HCMV genes nor by an increase in cellular IL10. Rat bone marrow derived dendritic cells (BMDC) were highly susceptible to infection with RCMV and a recombinant RCMV expressing eGFP. RCMV infection of BMDCs depleted both surface and intracellular MHC II to nearly undetectable levels as well as reduced surface expression of MHC I. The effect on MHC II only occurred in the infected GFP positive cells and is mediated by an immediate early or early viral gene product. Furthermore, treatment of uninfected immature DCs with virus-free conditioned supernatants from infected cells failed to down regulate MHC II. RCMV depletion of MHC II was sensitive to treatment with lysosomal inhibitors but not proteasomal inhibitors suggesting that the mechanism of RCMV-mediated down regulation of MHC II occurs through endocytic degradation. Since RCMV does not encode homologues of US2, US3, UL83 or UL111a, these data indicate a novel mechanism for RCMV depletion of MHC II.

Indexed as

AnimalsBone Marrow CellsCytomegalovirus InfectionsDendritic CellsDown-RegulationGene Expression RegulationGenes, MHC Class IGenes, MHC Class IIRats

Identifiers

PMID19349057
PMCPMC2749604
OpenAlexW2037593060

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.